Marshall Wace North America’s Magellan Health Services, Inc. MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,132
Closed -$167K 1723
2019
Q4
$167K Buy
+2,132
New +$150K ﹤0.01% 1001
2019
Q1
Sell
-7,250
Closed -$412K 2026
2018
Q4
$412K Buy
+7,250
New +$447K ﹤0.01% 818
2018
Q1
Sell
-4,576
Closed -$442K 1798
2017
Q4
$442K Buy
+4,576
New +$405K ﹤0.01% 1168
2017
Q3
Sell
-5,711
Closed -$417K 1597
2017
Q2
$417K Buy
+5,711
New +$401K ﹤0.01% 1121

Other funds holding MGLN

Marshall Wace North America's MGLN Position: Q1 2020 in Review

Marshall Wace North America sold out of Magellan Health Services, Inc. (MGLN) in Q1 2020, closing a stake of 2,132 shares — an estimated $167K sold.

Marshall Wace North America first reported a position in MGLN in Q2 2017 and held it in 4 quarters. The position peaked at $442K in Q4 2017. 168 funds tracked by Wall St. Rank hold MGLN as of Q1 2020.

  • Marshall Wace North America reported no remaining Magellan Health Services, Inc. position as of Q1 2020 after selling out during the quarter.
  • Marshall Wace North America sold 2,132 Magellan Health Services, Inc. shares in Q1 2020, an estimated $167K.
  • Marshall Wace North America first reported a position in Magellan Health Services, Inc. in Q2 2017 and held it in 4 quarters.
  • Marshall Wace North America's Magellan Health Services, Inc. position peaked at $442K in Q4 2017.
  • 168 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2020.

Based on Marshall Wace North America's 13F filing for Q1 2020, filed 15 May 2020.